The accelerating Biosimulation Market Growth is driven by a powerful confluence of regulatory, technological, and clinical drivers that are fundamentally altering the drug development landscape. Regulatory bodies, including the FDA and EMA, have increasingly formalized the use of modeling and simulation data, often through initiatives like Model-Informed Drug Development (MIDD), to...